Pakistan

Pakistan

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.3 (2.04 - 2.61) 2019 Modelled IHME
2.31 (2.05 - 2.61) 2018 Modelled IHME
2.34 (2.05 - 2.66) 2017 Modelled IHME
2.48 (2.18 - 2.80) 2016 Modelled IHME
2.61 (2.30 - 2.93) 2015 Modelled IHME
2.58 (2.29 - 2.88) 2014 Modelled IHME
2.52 (2.27 - 2.79) 2013 Modelled IHME
2.45 (2.23 - 2.69) 2012 Modelled IHME
2.38 (2.19 - 2.61) 2011 Modelled IHME
2.36 (2.17 - 2.57) 2010 Modelled IHME
2.37 (2.18 - 2.57) 2009 Modelled IHME
2.39 (2.21 - 2.59) 2008 Modelled IHME
2.42 (2.24 - 2.62) 2007 Modelled IHME
2.46 (2.27 - 2.66) 2006 Modelled IHME
2.5 (2.31 - 2.70) 2005 Modelled IHME
2.55 (2.36 - 2.75) 2004 Modelled IHME
2.61 (2.40 - 2.83) 2003 Modelled IHME
2.68 (2.46 - 2.91) 2002 Modelled IHME
2.75 (2.52 - 3.01) 2001 Modelled IHME
2.84 (2.58 - 3.12) 2000 Modelled IHME
2.95 (2.68 - 3.25) 1999 Modelled IHME
3.08 (2.81 - 3.39) 1998 Modelled IHME
3.22 (2.93 - 3.54) 1997 Modelled IHME
3.35 (3.02 - 3.69) 1996 Modelled IHME
3.44 (3.08 - 3.81) 1995 Modelled IHME
3.51 (3.11 - 3.93) 1994 Modelled IHME
3.57 (3.13 - 4.03) 1993 Modelled IHME
3.63 (3.15 - 4.12) 1992 Modelled IHME
3.67 (3.16 - 4.21) 1991 Modelled IHME
3.7 (3.15 - 4.30) 1990 Modelled IHME
5.63 (4.44 - 7.31) 2015 Modelled WHO
2.76 (2.73 - 2.79) 2013 Modelled Schweitzer et al, 2015
2.5 2010 Survey/reported Qureshi et al, 2010
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.54 (0.43 - 0.68) 2019 Modelled IHME
0.57 (0.45 - 0.71) 2018 Modelled IHME
0.6 (0.48 - 0.75) 2017 Modelled IHME
0.64 (0.51 - 0.79) 2016 Modelled IHME
0.67 (0.54 - 0.83) 2015 Modelled IHME
0.68 (0.55 - 0.83) 2014 Modelled IHME
0.69 (0.56 - 0.83) 2013 Modelled IHME
0.69 (0.57 - 0.83) 2012 Modelled IHME
0.7 (0.57 - 0.83) 2011 Modelled IHME
0.7 (0.58 - 0.83) 2010 Modelled IHME
0.71 (0.58 - 0.84) 2009 Modelled IHME
0.71 (0.59 - 0.84) 2008 Modelled IHME
0.72 (0.60 - 0.85) 2007 Modelled IHME
0.73 (0.60 - 0.86) 2006 Modelled IHME
0.74 (0.62 - 0.87) 2005 Modelled IHME
0.85 (0.71 - 1) 2004 Modelled IHME
1.12 (0.92 - 1.31) 2003 Modelled IHME
1.44 (1.18 - 1.69) 2002 Modelled IHME
1.73 (1.42 - 2.04) 2001 Modelled IHME
1.91 (1.57 - 2.27) 2000 Modelled IHME
2.01 (1.64 - 2.39) 1999 Modelled IHME
2.08 (1.71 - 2.50) 1998 Modelled IHME
2.15 (1.77 - 2.58) 1997 Modelled IHME
2.2 (1.80 - 2.66) 1996 Modelled IHME
2.23 (1.81 - 2.72) 1995 Modelled IHME
2.26 (1.82 - 2.77) 1994 Modelled IHME
2.28 (1.81 - 2.82) 1993 Modelled IHME
2.3 (1.82 - 2.86) 1992 Modelled IHME
2.32 (1.82 - 2.90) 1991 Modelled IHME
2.33 (1.81 - 2.96) 1990 Modelled IHME
2.75 (2.02 - 3.67) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.23 (5.30 - 9.67) 2019 Modelled IHME
7.26 (5.25 - 9.75) 2018 Modelled IHME
7.3 (5.27 - 9.76) 2017 Modelled IHME
7.25 (5.28 - 9.58) 2016 Modelled IHME
7.26 (5.25 - 9.54) 2015 Modelled IHME
7.33 (5.45 - 9.62) 2014 Modelled IHME
7.38 (5.43 - 9.64) 2013 Modelled IHME
7.4 (5.50 - 9.68) 2012 Modelled IHME
7.48 (5.35 - 9.72) 2011 Modelled IHME
7.57 (5.54 - 9.79) 2010 Modelled IHME
7.63 (5.58 - 9.82) 2009 Modelled IHME
7.67 (5.75 - 9.81) 2008 Modelled IHME
7.7 (5.73 - 9.85) 2007 Modelled IHME
7.79 (5.83 - 9.85) 2006 Modelled IHME
7.89 (6.04 - 9.93) 2005 Modelled IHME
8 (6.05 - 10) 2004 Modelled IHME
8.13 (6.11 - 10.20) 2003 Modelled IHME
8.27 (6.17 - 10.40) 2002 Modelled IHME
8.37 (6.22 - 10.60) 2001 Modelled IHME
8.4 (6.13 - 10.80) 2000 Modelled IHME
8.39 (6.17 - 10.70) 1999 Modelled IHME
8.46 (6.19 - 10.80) 1998 Modelled IHME
8.6 (6.19 - 11) 1997 Modelled IHME
8.67 (6.06 - 11.20) 1996 Modelled IHME
8.69 (6.06 - 11.50) 1995 Modelled IHME
8.6 (5.87 - 11.60) 1994 Modelled IHME
8.57 (5.64 - 11.60) 1993 Modelled IHME
8.59 (5.59 - 11.80) 1992 Modelled IHME
8.57 (5.48 - 12.10) 1991 Modelled IHME
8.56 (5.41 - 12.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
16,208 (11,878 - 21,656) 2019 Modelled IHME
15,916 (11,508 - 21,399) 2018 Modelled IHME
15,686 (11,324 - 20,956) 2017 Modelled IHME
15,249 (11,104 - 20,149) 2016 Modelled IHME
14,927 (10,797 - 19,620) 2015 Modelled IHME
14,749 (10,970 - 19,338) 2014 Modelled IHME
14,515 (10,671 - 18,946) 2013 Modelled IHME
14,209 (10,556 - 18,591) 2012 Modelled IHME
14,023 (10,034 - 18,218) 2011 Modelled IHME
13,860 (10,135 - 17,916) 2010 Modelled IHME
13,622 (9,966 - 17,526) 2009 Modelled IHME
13,359 (10,008 - 17,093) 2008 Modelled IHME
13,074 (9,734 - 16,719) 2007 Modelled IHME
12,898 (9,656 - 16,298) 2006 Modelled IHME
12,732 (9,747 - 16,025) 2005 Modelled IHME
12,584 (9,524 - 15,756) 2004 Modelled IHME
12,465 (9,378 - 15,639) 2003 Modelled IHME
12,370 (9,232 - 15,624) 2002 Modelled IHME
12,201 (9,063 - 15,388) 2001 Modelled IHME
11,948 (8,715 - 15,402) 2000 Modelled IHME
11,638 (8,562 - 14,813) 1999 Modelled IHME
11,459 (8,383 - 14,627) 1998 Modelled IHME
11,372 (8,182 - 14,594) 1997 Modelled IHME
11,202 (7,830 - 14,491) 1996 Modelled IHME
10,973 (7,655 - 14,565) 1995 Modelled IHME
10,612 (7,238 - 14,262) 1994 Modelled IHME
10,342 (6,811 - 14,010) 1993 Modelled IHME
10,135 (6,599 - 13,963) 1992 Modelled IHME
9,894 (6,329 - 13,986) 1991 Modelled IHME
9,657 (6,100 - 13,729) 1990 Modelled IHME
15,531 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
18 (15 - 21) 2019 Modelled IHME
18 (15 - 21) 2018 Modelled IHME
18 (14 - 21) 2017 Modelled IHME
18 (15 - 21) 2016 Modelled IHME
18 (15 - 21) 2015 Modelled IHME
18 (15 - 21) 2014 Modelled IHME
18 (15 - 21) 2013 Modelled IHME
18 (15 - 21) 2012 Modelled IHME
18 (15 - 21) 2011 Modelled IHME
18 (15 - 21) 2010 Modelled IHME
18 (15 - 21) 2009 Modelled IHME
18 (15 - 21) 2008 Modelled IHME
18 (15 - 21) 2007 Modelled IHME
17 (15 - 21) 2006 Modelled IHME
17 (15 - 21) 2005 Modelled IHME
17 (15 - 21) 2004 Modelled IHME
17 (14 - 21) 2003 Modelled IHME
17 (14 - 20) 2002 Modelled IHME
17 (14 - 21) 2001 Modelled IHME
17 (14 - 20) 2000 Modelled IHME
17 (14 - 20) 1999 Modelled IHME
17 (14 - 20) 1998 Modelled IHME
17 (14 - 20) 1997 Modelled IHME
17 (14 - 20) 1996 Modelled IHME
16 (14 - 20) 1995 Modelled IHME
16 (13 - 19) 1994 Modelled IHME
16 (13 - 19) 1993 Modelled IHME
16 (13 - 19) 1992 Modelled IHME
16 (13 - 19) 1991 Modelled IHME
16 (13 - 19) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
75 2018 Survey/reported WHO/UNICEF
75 2017 Survey/reported WHO/UNICEF
75 2016 Survey/reported WHO/UNICEF
72 2015 Survey/reported WHO/UNICEF
69 2014 Survey/reported WHO/UNICEF
65 2013 Survey/reported WHO/UNICEF
64 2012 Survey/reported WHO/UNICEF
63 2011 Survey/reported WHO/UNICEF
52 2010 Survey/reported WHO/UNICEF
52 2009 Survey/reported WHO/UNICEF
53 2008 Survey/reported WHO/UNICEF
54 2007 Survey/reported WHO/UNICEF
60 2006 Survey/reported WHO/UNICEF
65 2005 Survey/reported WHO/UNICEF
62 2004 Survey/reported WHO/UNICEF
62 2003 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
18 (16 - 21) 2015 Survey/reported Pakistan National AIDS Control Program, 2015

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2015 Survey/reported NACP, 2015.
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Eligible for HBV generic medicines
Year of birth dose introduction
2016
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.68 (1.34 - 2.09) 2019 Modelled IHME
1.69 (1.34 - 2.09) 2018 Modelled IHME
1.69 (1.35 - 2.09) 2017 Modelled IHME
1.9 (1.53 - 2.36) 2016 Modelled IHME
2.16 (1.75 - 2.68) 2015 Modelled IHME
2.27 (1.83 - 2.82) 2014 Modelled IHME
2.36 (1.91 - 2.92) 2013 Modelled IHME
2.43 (1.96 - 3.01) 2012 Modelled IHME
2.48 (2 - 3.07) 2011 Modelled IHME
2.5 (2.01 - 3.09) 2010 Modelled IHME
2.5 (2.01 - 3.09) 2009 Modelled IHME
2.49 (2.01 - 3.07) 2008 Modelled IHME
2.48 (2 - 3.06) 2007 Modelled IHME
2.47 (1.99 - 3.04) 2006 Modelled IHME
2.46 (1.98 - 3.02) 2005 Modelled IHME
2.39 (1.93 - 2.96) 2004 Modelled IHME
2.27 (1.84 - 2.80) 2003 Modelled IHME
2.13 (1.72 - 2.62) 2002 Modelled IHME
2.02 (1.63 - 2.49) 2001 Modelled IHME
1.97 (1.59 - 2.44) 2000 Modelled IHME
1.99 (1.60 - 2.45) 1999 Modelled IHME
2.02 (1.62 - 2.48) 1998 Modelled IHME
2.06 (1.65 - 2.53) 1997 Modelled IHME
2.09 (1.68 - 2.58) 1996 Modelled IHME
2.11 (1.68 - 2.60) 1995 Modelled IHME
2.1 (1.69 - 2.59) 1994 Modelled IHME
2.1 (1.68 - 2.59) 1993 Modelled IHME
2.09 (1.67 - 2.59) 1992 Modelled IHME
2.06 (1.65 - 2.58) 1991 Modelled IHME
2.04 (1.63 - 2.55) 1990 Modelled IHME
3.8 (2.80 - 3.90) 2015 Modelled Blach et al, 2017
5.8 (1.40 - 8.70) 2014 Modelled Gower et al, 2014
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
6.7 (1.60 - 1) 2014 Modelled Gower et al, 2014
4.8 2010 Survey/reported Qureshi et al, 2010
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
36.5 (0 - 79.10) 2013 Modelled Degenhardt L et al, 2017

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.87 (5.69 - 11) 2019 Modelled IHME
8.03 (5.78 - 10.90) 2018 Modelled IHME
8.15 (5.94 - 11) 2017 Modelled IHME
8.13 (6 - 10.90) 2016 Modelled IHME
8.16 (5.96 - 11) 2015 Modelled IHME
8.24 (6.09 - 11.10) 2014 Modelled IHME
8.27 (5.99 - 11.10) 2013 Modelled IHME
8.25 (6.07 - 11) 2012 Modelled IHME
8.31 (6.19 - 10.90) 2011 Modelled IHME
8.4 (6.24 - 11) 2010 Modelled IHME
8.47 (6.35 - 11.10) 2009 Modelled IHME
8.53 (6.63 - 11.20) 2008 Modelled IHME
8.59 (6.60 - 11.10) 2007 Modelled IHME
8.7 (6.68 - 11.10) 2006 Modelled IHME
8.82 (6.81 - 11.30) 2005 Modelled IHME
8.96 (7 - 11.60) 2004 Modelled IHME
9.11 (7.08 - 11.60) 2003 Modelled IHME
9.27 (7.18 - 12) 2002 Modelled IHME
9.38 (7.23 - 12.10) 2001 Modelled IHME
9.45 (7.22 - 12.40) 2000 Modelled IHME
9.48 (7.18 - 12.50) 1999 Modelled IHME
9.6 (7.17 - 12.90) 1998 Modelled IHME
9.78 (7.28 - 13.10) 1997 Modelled IHME
9.89 (7.14 - 13.50) 1996 Modelled IHME
9.96 (7.09 - 13.90) 1995 Modelled IHME
9.91 (6.88 - 14.10) 1994 Modelled IHME
9.92 (6.73 - 14.40) 1993 Modelled IHME
9.99 (6.61 - 14.70) 1992 Modelled IHME
10 (6.50 - 14.90) 1991 Modelled IHME
10.1 (6.43 - 15.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
17,644 (12,752 - 24,554) 2019 Modelled IHME
17,606 (12,684 - 23,927) 2018 Modelled IHME
17,502 (12,769 - 23,584) 2017 Modelled IHME
17,094 (12,617 - 22,890) 2016 Modelled IHME
16,793 (12,256 - 22,683) 2015 Modelled IHME
16,569 (12,252 - 22,347) 2014 Modelled IHME
16,252 (11,766 - 21,883) 2013 Modelled IHME
15,845 (11,655 - 21,185) 2012 Modelled IHME
15,579 (11,600 - 20,467) 2011 Modelled IHME
15,371 (11,414 - 20,171) 2010 Modelled IHME
15,122 (11,335 - 19,790) 2009 Modelled IHME
14,862 (11,539 - 19,580) 2008 Modelled IHME
14,579 (11,208 - 18,799) 2007 Modelled IHME
14,395 (11,063 - 18,452) 2006 Modelled IHME
14,232 (10,984 - 18,192) 2005 Modelled IHME
14,098 (11,009 - 18,265) 2004 Modelled IHME
13,975 (10,856 - 17,735) 2003 Modelled IHME
13,861 (10,739 - 17,926) 2002 Modelled IHME
13,671 (10,545 - 17,661) 2001 Modelled IHME
13,440 (10,269 - 17,568) 2000 Modelled IHME
13,148 (9,955 - 17,386) 1999 Modelled IHME
12,993 (9,708 - 17,473) 1998 Modelled IHME
12,925 (9,625 - 17,267) 1997 Modelled IHME
12,775 (9,227 - 17,400) 1996 Modelled IHME
12,572 (8,953 - 17,585) 1995 Modelled IHME
12,227 (8,487 - 17,376) 1994 Modelled IHME
11,973 (8,126 - 17,396) 1993 Modelled IHME
11,786 (7,806 - 17,382) 1992 Modelled IHME
11,566 (7,503 - 17,243) 1991 Modelled IHME
11,379 (7,256 - 17,165) 1990 Modelled IHME
12,122 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
50 (44 - 54) 2019 Modelled IHME
50 (45 - 55) 2018 Modelled IHME
50 (44 - 54) 2017 Modelled IHME
49 (44 - 54) 2016 Modelled IHME
49 (44 - 54) 2015 Modelled IHME
49 (44 - 54) 2014 Modelled IHME
49 (44 - 54) 2013 Modelled IHME
50 (44 - 54) 2012 Modelled IHME
50 (45 - 54) 2011 Modelled IHME
50 (45 - 54) 2010 Modelled IHME
50 (45 - 54) 2009 Modelled IHME
50 (45 - 54) 2008 Modelled IHME
50 (45 - 55) 2007 Modelled IHME
50 (45 - 55) 2006 Modelled IHME
50 (45 - 55) 2005 Modelled IHME
50 (45 - 55) 2004 Modelled IHME
51 (45 - 55) 2003 Modelled IHME
51 (46 - 56) 2002 Modelled IHME
51 (46 - 56) 2001 Modelled IHME
51 (46 - 56) 2000 Modelled IHME
51 (46 - 56) 1999 Modelled IHME
52 (46 - 56) 1998 Modelled IHME
52 (47 - 57) 1997 Modelled IHME
52 (47 - 57) 1996 Modelled IHME
52 (47 - 57) 1995 Modelled IHME
52 (47 - 57) 1994 Modelled IHME
52 (47 - 57) 1993 Modelled IHME
53 (47 - 57) 1992 Modelled IHME
53 (47 - 58) 1991 Modelled IHME
53 (47 - 58) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
18 (16 - 21) 2015 Survey/reported Pakistan National AIDS Control Program, 2015

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2015 Survey/reported NACP, 2015.
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Eligible for HBV generic medicines
Year of birth dose introduction
2016
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Hepatitis related deaths (national)

Modelled

HBV
16,208
2019
(11,878 - 21,656)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
17,644
2019
(12,752 - 24,554)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
18
2015
(16 - 21)
Pakistan National AIDS Control Program, 2015
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources